Trials that use: P-values
New to this method? Read the tutorial →
20,601 results
- Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Enhancement of Cerebral Vasoreactivity and Cognition by Intranasal Insulin in Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Enhancement of Corticosteroid Efficacy in COPD: Complete Statistical AnalysisIndependent statistical analysis of Enhancement of Corticosteroid Efficacy in COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02340520).
- Enhancement of in-Vitro GC Function in Patients With COPD: Complete Statistical AnalysisIndependent statistical analysis of Enhancement of in-Vitro GC Function in Patients With COPD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00241631).
- Enhancement of Pressure Healing With Pulsatile Lavage: Complete Statistical AnalysisIndependent statistical analysis of Enhancement of Pressure Healing With Pulsatile Lavage: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00047619).
- Enhancing Adolescent Substance Abuse Treatment: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Adolescent Substance Abuse Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03249350).
- Enhancing Caregiver Support for Heart Failure Patients: the CarePartner Study: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Caregiver Support for Heart Failure Patients: the CarePartner Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00555360).
- Enhancing Cognitive Control in Mild Cognitive Impairment Via Non-invasive Brain Stimulation: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Cognitive Control in Mild Cognitive Impairment Via Non-invasive Brain Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Enhancing Community Capacity to Improve Cancer Care Delivery: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Community Capacity to Improve Cancer Care Delivery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04107116).
- Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Disrupted Reconsolidation: Impact on Cocaine Craving: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01822587).
- Enhancing Exposure Therapy for Post Traumatic Stress Disorder (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Exposure Therapy for Post Traumatic Stress Disorder (PTSD): Virtual Reality and Imaginal Exposure With a Cognitive Enhancer: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Enhancing Fitness in Older Pre-diabetic Veterans: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Fitness in Older Pre-diabetic Veterans: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00594399).
- Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Osteoporosis Therapy: Can We Open the Anabolic Window?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01166958).
- Enhancing Patient Ability to Understand and Utilize Complex Information Concerning Medication Self-management: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Patient Ability to Understand and Utilize Complex Information Concerning Medication Self-management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Enhancing Plasticity in Stroke Patients With Severe Motor Deficit: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Plasticity in Stroke Patients With Severe Motor Deficit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02633215).
- Enhancing Self Regulation as a Strategy for Obesity Prevention in Head Start Preschoolers: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Self Regulation as a Strategy for Obesity Prevention in Head Start Preschoolers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Spatial Navigation Using Non-Invasive Brain Stimulation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01958437).
- Enhancing the Effects of Adolescent Alcohol Treatment With Atomoxetine: Complete Statistical AnalysisIndependent statistical analysis of Enhancing the Effects of Adolescent Alcohol Treatment With Atomoxetine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04565288).
- Enhancing Well-Being Through Exercise During Old Age: Complete Statistical AnalysisIndependent statistical analysis of Enhancing Well-Being Through Exercise During Old Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04536727).
- ENLIGHTENIndependent statistical analysis of A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- ENLIGHTENIndependent statistical analysis of ENLIGHTEN: Establishing Novel Antiretroviral (ARV) Imaging for Hair to Elucidate Non-Adherence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- ENLIGHTEN 1Independent statistical analysis of Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ENLIGHTENmeIndependent statistical analysis of Population Based Lighting Study on Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05676086).
- EnligHTN-IVIndependent statistical analysis of EnligHTN IV Trial - Multicenter Sham-controlled RCT of Renal Denervation for Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- ENLIVENIndependent statistical analysis of Study Evaluating the Safety, Efficacy and Tolerability of BIO89-100 in Subjects With Biopsy-confirmed Nonalcoholic Steatohepatitis (NASH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ENRICHIndependent statistical analysis of Early Intervention to Promote Cardiovascular Health of Mothers and Children (ENRICH): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EnsembleIndependent statistical analysis of Ensemble Programme an Early Intervention for Informal Caregivers of Psychiatric Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B: Complete Statistical AnalysisIndependent statistical analysis of Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection: Complete Statistical AnalysisIndependent statistical analysis of Entecavir/Pegylated Interferon in Immune Tolerant Children With Chronic Hepatitis B Virus (HBV) Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Enterra Therapy Clinical Study (Gastric Stimulation for Gastroparesis): Complete Statistical AnalysisIndependent statistical analysis of Enterra Therapy Clinical Study (Gastric Stimulation for Gastroparesis): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00157755).
- ENTHRALLIndependent statistical analysis of Effect of Niacin on Transport of HDL and Relationship to Atherogenic Lipoproteins and Lipolysis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination: Complete Statistical AnalysisIndependent statistical analysis of Entolimod on Immunosenescence in Healthy Geriatric Subjects Receiving Influenza Vaccination: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04176133).
- Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Entospletinib in Combination With Idelalisib in Adults With Relapsed or Refractory Hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- ENTRUST-AF-PCIIndependent statistical analysis of Edoxaban Treatment Versus Vitamin K Antagonist in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Envarsus Neurotoxicity Burden in Liver Transplant Patients: Complete Statistical AnalysisIndependent statistical analysis of Envarsus Neurotoxicity Burden in Liver Transplant Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03823768).
- Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Environmental Design for Behavioral Regulation in People With Dementia: Complete Statistical AnalysisIndependent statistical analysis of Environmental Design for Behavioral Regulation in People With Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04555616).
- Environmental Treatment for Seasonal Affective Disorder (SAD): Complete Statistical AnalysisIndependent statistical analysis of Environmental Treatment for Seasonal Affective Disorder (SAD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00139997).
- ENVISIONIndependent statistical analysis of A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- ENVISIONIndependent statistical analysis of A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- EnvisionIndependent statistical analysis of A Study to Investigate the Efficacy, Safety, and Tolerability of JNJ-42165279 in Adolescent and Adult Participants With Autism Spectrum Disorder: primary endpoint results, effect estimate with confidence interval,…
- ENVISIONIndependent statistical analysis of Phase 3 Extension Study of Dexpramipexole in ALS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01622088).
- Enzalutamide for Bladder Cancer Chemoprevention: Complete Statistical AnalysisIndependent statistical analysis of Enzalutamide for Bladder Cancer Chemoprevention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02605863).
- Enzalutamide in Patients With High-risk Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Enzalutamide in Patients With High-risk Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01927627).
- Enzastaurin for Patients With Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Enzastaurin for Patients With Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00192114).
- Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- EoEIndependent statistical analysis of Value of Patch Testing in Direct Diet Therapy for Eosinophilic Esophagitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- EOEIndependent statistical analysis of Study of the Efficiency of Esophageal Dilation on Patient With Eosinophilic Esophagitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- EOSIndependent statistical analysis of Effect of Roflumilast on Lung Function in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Salmeterol: The EOS Study (BY217/M2-127): primary endpoint results, effect estimate with confidence interval,…
- Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids: Complete Statistical AnalysisIndependent statistical analysis of Eosinophilic Esophagitis Intervention Trial-1 Food vs. 4 Food Elimination Diet Followed by Swallowed Glucocorticoids: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Eovist vs. Dotarem Healthy Volunteer MRI: Complete Statistical AnalysisIndependent statistical analysis of Eovist vs. Dotarem Healthy Volunteer MRI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02431598).